Myostatin as a fibroblast-activating factor impacts on postoperative outcome in patients with hepatocellular carcinoma期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Myostatin as a fibroblast-activating factor impacts on postoperative outcome in patients with hepatocellular carcinoma

Authors:	Sachiyo Yoshio Tomonari Shimagaki Ryuki Hashida Takumi Kawaguchi Yuriko Tsutsui Yuzuru Sakamoto Yuichi Yoshida Hironari Kawai Shiori Yoshikawa Taiji Yamazoe Taizo Mori Yosuke Osawa Shinji Itoh Moto Fukai Tomoharu Yoshizumi Akinobu Taketomi Masaki Mori Tatsuya Kanto

Institution:	1. Department of Liver Disease, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan;2. Department of Liver Disease, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;3. Division of Rehabilitation, Department of Rehabilitation, Kurume University School of Medicine, Kurume, Japan;4. Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan;5. Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;6. Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan

Abstract:

Keywords:	exercise liver fibrosis myokine NAFLD primary fibroblast sarcopenia